東華科技(002140.SZ):與黔希化工、中化學資產簽訂債務承擔協議(閉口)
格隆匯9月30日丨東華科技(002140.SZ)公佈,公司與黔西縣黔希煤化工投資有限責任公司(“黔希化工”)、中化學資產管理有限公司(“中化學資產”)就黔希化工欠付公司剩餘工程款事項達成《債務承擔協議》(閉口),由中化學資產作為新債務人,承擔黔希化工所欠公司的剩餘工程款計36399.15萬元。中化學資產按年度分期支付上述款項,至2025年12月31日前支付完畢。
中化學資產系公司控股股東化學工業第三設計院有限公司的控股股東中國化學工程股份有限公司的全資子公司,公司與黔希化工、中化學資產簽訂《債務承擔協議》(閉口)構成關聯交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.